IPAC-RS has published specific best practice recommendations for leachables and extractables testing of OINDPs
List of excipients: Therapeutic indications: Contraindications: Marketing Authorisation Holder: Only available on prescription and in pharmacies More information about pharmaceutical form, posology and method of administration, special warnings and precautions for use, interaction with other medicinal products and other forms of interaction, fertility, pregnancy and lactation, effects on ability to drive and use machines, undesirable effects, overdose, pharmacodynamics properties, pharmacokinetic properties, preclinical safety data, incompatibilities, shelf life, special precautions for storage, nature and contents of the container and special precautions for disposal is available in the summary of product characteristics
Roberson, S.J
Kupferpeptide werden oft als sanftere Option innerhalb einer Anti-Aging-Routine beschrieben
Targeting different sites involved in Caspase interactions with XIAP using small-molecule chemical inhibitors induces synergistic apoptosis of leukemia cells
